Sponsor:
Legend Labz, Inc.
Code:
NCT05413226
Conditions
Safety Issues
Eligibility Criteria
Sex: Male
Age: 18 - 40
Healthy Volunteers: Accepted
Interventions
Celastrol
Brief summary:
Conditions
Safety Issues
Study ID
NCT05413226
Start date
Sep 28, 2021
Status verified date
Jun, 2022
Completion date
Jul 15, 2022
Anticipated
Primary completion date
Jul 15, 2022
Anticipated
Eligibility Criteria
Sex: Male
Age: 18 - 40
Healthy Volunteers: Accepted
Enrollment
5 participants
Anticipated
Intervention Model
Sequential
Primary purpose
Basic Science
Arms
experimental: Amount of Celastrol Administered
Interventions
Celastrol
Primary outcome measure
Central contacts
Locations
Patient Urgent Care Clinic
Recruiting
Baton Rouge, Louisiana, United States, 70808
Contacts
Sponsor
Legend Labz, Inc.
Last update posted
Jun 9, 2022
Last verified
Jun, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Legend Labz, Inc. on 2022-06-09.